Jundishapur Journal of Microbiology

Published by: Kowsar

Successful Treatment of Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Recurrent Urinary Tract Infection with High Doses of Amoxicillin with Clavulanic Acid in a Kidney Transplant Recipients: A Case Report

Piotr Wilkowski 1 , Michal Ciszek 1 , * , Kornelia Dobrzaniecka 2 , Monika Wojtowicz 1 , Dariusz Wasiak 3 , Grazyna Mlynarczyk 2 and Leszek Paczek 1
Authors Information
1 Department of Immunology, Transplant Medicine and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
2 Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland
3 Department of Surgical and Transplantation Nursing, Warsaw Medical University, Warsaw, Poland
Article information
  • Jundishapur Journal of Microbiology: November 2017, 10 (11); e57647
  • Published Online: October 28, 2017
  • Article Type: Case Report
  • Received: July 6, 2017
  • Accepted: August 25, 2017
  • DOI: 10.5812/jjm.57647

To Cite: Wilkowski P, Ciszek M, Dobrzaniecka K, Wojtowicz M, Wasiak D, et al. Successful Treatment of Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Recurrent Urinary Tract Infection with High Doses of Amoxicillin with Clavulanic Acid in a Kidney Transplant Recipients: A Case Report, Jundishapur J Microbiol. 2017 ; 10(11):e57647. doi: 10.5812/jjm.57647.

Abstract
Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Acknowledgements
Footnotes
References
  • 1. Espinar MJ, Miranda IM, Costa-de-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum beta-Lactamases: Risk Factors and Molecular Epidemiology. PLoS One. 2015; 10(8)[DOI][PubMed]
  • 2. Latifpour M, Gholipour A, Damavandi MS. Prevalence of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates in Nosocomial and Community-Acquired Urinary Tract Infections. Jundishapur J Microbiol. 2016; 9(3)[DOI][PubMed]
  • 3. Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, et al. Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. Transpl Infect Dis. 2016; 18(5): 777-81[DOI][PubMed]
  • 4. Mlynarczyk G, Kosykowska E, de Walthoffen SW, Szymanek-Majchrzak K, Sawicka-Grzelak A, Baczkowska T, et al. A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients. Transplant Proc. 2011; 43(8): 3135-6[DOI][PubMed]
  • 5. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4): 657-86[DOI][PubMed]
  • 6. Pouch SM, Kubin CJ, Satlin MJ, Tsapepas DS, Lee JR, Dube G, et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients. Transpl Infect Dis. 2015; 17(6): 800-9[DOI][PubMed]
  • 7. Zullo A, Ridola L, Francesco VD, Gatta L, Hassan C, Alvaro D, et al. High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study. Ann Gastroenterol. 2015; 28(4): 448-51[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments